Orforglipron

Overview

Orforglipron (LY3502970) represents a unique approach to GLP-1 receptor research. Unlike traditional peptide-based ligands, this small-molecule agonist is designed for oral bioavailability, making it an interesting candidate for various experimental applications. Developed by Eli Lilly and Company, its structural simplicity allows researchers to explore GLP-1 receptor signaling in innovative ways.

Key Features

• 99% purity level, ensuring high quality
• Third-party tested for added reliability
• Free shipping on U.S. orders over $100
• Proudly manufactured in the USA
• Fast and reliable shipping options
• Secure checkout process

Specifications

Purity	99%
Form	Capsules
Manufacturer	Eli Lilly and Company

FAQ

What is Orforglipron?

Orforglipron is a non-peptide, small-molecule agonist that targets the GLP-1 receptor, designed for research purposes.

How is Orforglipron tested for purity?

This product has undergone third-party testing to confirm its purity level of 99%.

What shipping options are available?

We offer free shipping on U.S. orders over $100, along with fast and reliable delivery options.

Explore the potential of Orforglipron for your research needs. Order now to take advantage of our free shipping offer and ensure you have the best materials at your disposal.

Related Products

• MK-777 (Acetamoren)
• BAM-15 + SLU-PP-332 Capsules
• Apigenin Powder

Browse more in Caps & Tabs.

Always read the label and use products as directed. Consult a qualified professional where appropriate.